[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "README exclamation ... INFORMATION SHALL DDA spiked compound DOID MHC depletion PO WARRANTY TIP CLO WILL UBERON URL developmental stage organism part pooled sample data file characteristics WARRANTIES label XML alkylation reagent sample COULD CPTAC NCBI sex ISA DIA RECOMMEND NT PMCID OF MUST individual MS:1001251 REQUIRED ancestry category DTT ZFA NCE EBI RAW fraction identifier MT RFC MONDO CT XL organism reduction reagent IS PSI LI OR cleavage agent details EW MAJOR URI NOTE RECOMMENDED biosample accession number instrument age mass PROTEOMICS proteomics data acquisition method TAB INCLUDING DISCLAIMS PTM file your NOT ALL SP CS REQUIRES MERCHANTABILITY USE BE CL COLUMN FOR IMPORTANT SRM PRM disease stage BTO TA SH MS MIAME CN DJ RIGHTS SDRF PRIDE BRENDA SHOULD INFRINGE PMID FITNESS AC PS PEPTIDESEQ PARTICULAR SWATH MAGE IAA TO HANCESTRO BMC dissociation method MAY disease STANDARDS CID II IMPLIED LIMITED SILAC technical replicate source name_ and _assay name OPTIONAL replicate HUPO HEREIN cell type MINOR biological replicate THAT source name CELL PATCH JA BUT EM fractionation method AS ID III QY HTML HF VCF HCD CV THE PURPOSE VK EXPRESS TMT CF MOD PP ANY ROW FDR EFO PATO SN IDF INITIATIVE PRIDE:0000659 ENVO collision energy MC LC"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "README ... INFORMATION SHALL DDA spiked compound DOID MHC depletion PO WARRANTY WILL CLO UBERON URL organism part pooled sample data file WARRANTIES label alkylation reagent COULD CPTAC NCBI sex ISA DIA RECOMMEND NT PMCID OF MUST individual MS:1001251 REQUIRED ancestry category DTT ZFA NCE EBI RAW fraction identifier MT RFC MONDO CT XL organism reduction reagent IS PSI LI OR cleavage agent details EW MAJOR URI RECOMMENDED biosample accession number instrument age mass PROTEOMICS proteomics data acquisition method TAB INCLUDING DISCLAIMS PTM NOT ALL SP CS REQUIRES MERCHANTABILITY USE BE CL COLUMN FOR SRM PRM disease stage BTO TA SH MS MIAME CN DJ RIGHTS SDRF PRIDE BRENDA SHOULD INFRINGE PMID FITNESS AC PS PEPTIDESEQ PARTICULAR SWATH MAGE IAA TO HANCESTRO BMC dissociation method MAY disease STANDARDS CID II IMPLIED LIMITED SILAC technical replicate OPTIONAL HUPO HEREIN cell type MINOR biological replicate THAT CELL PATCH JA BUT EM fractionation method AS III QY HTML HF VCF HCD CV THE PURPOSE VK EXPRESS TMT CF MOD PP ANY ROW FDR EFO PATO SN IDF INITIATIVE PRIDE:0000659 ENVO collision energy MC LC"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "exclamation CL:0000813 DOID depletion PO TIP UBERON URL PATO:0000383 developmental stage organism part CL:0000066 NCBI sex CL:0000084 CL:0000451 MONDO:0005180 MUST individual UBERON:0000178 MONDO:0005301 ancestry category MONDO UBERON:0000310 CL:0000235 CL:0000898 organism NOTE MONDO:0005138 age PDX PATO:0001340 CL:0000576 PTM ALL UBERON:0002097 CL:0000233 CL CL:0000540 UBERON:0001359 IMPORTANT CL:0000913 UBERON:0000948 PATO:0000461 CL:0000623 disease model MONDO:0005575 SDRF lib MONDO:0004946 MONDO:0005148 SHOULD UBERON:0002107 UBERON:0001155 CL:0000624 NSG APP HANCESTRO MONDO:0004989 MAY CL:0000787 disease PATO:0000384 CL:0000182 MONDO:0004975 UBERON:0002113 compound cell type UBERON:0001977 xenograft UBERON:0002048 CL:0000625 biological replicate source name UBERON:0000955 CL:0000057 enrichment process MONDO:0008383 UBERON:0001088 CSF ID MONDO:0005105 NK CL:0000232 CL:0000788 synthetic peptide MONDO:0100096 CL:0000815 COVID EFO PATO DSS CL:0000236 UBERON:0001969 CML"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000813 DOID depletion PO UBERON URL PATO:0000383 developmental stage organism part CL:0000066 NCBI sex CL:0000084 CL:0000451 MONDO:0005180 MUST individual UBERON:0000178 MONDO:0005301 ancestry category MONDO UBERON:0000310 CL:0000235 CL:0000898 organism MONDO:0005138 age PDX PATO:0001340 CL:0000576 PTM ALL UBERON:0002097 CL:0000233 CL CL:0000540 UBERON:0001359 CL:0000913 UBERON:0000948 PATO:0000461 CL:0000623 disease model MONDO:0005575 SDRF MONDO:0004946 MONDO:0005148 SHOULD UBERON:0002107 UBERON:0001155 CL:0000624 NSG APP HANCESTRO MONDO:0004989 MAY CL:0000787 disease PATO:0000384 CL:0000182 MONDO:0004975 UBERON:0002113 compound cell type UBERON:0001977 xenograft UBERON:0002048 CL:0000625 biological replicate source name UBERON:0000955 CL:0000057 enrichment process MONDO:0008383 UBERON:0001088 CSF ID MONDO:0005105 NK CL:0000232 CL:0000788 synthetic peptide MONDO:0100096 CL:0000815 COVID EFO PATO DSS CL:0000236 UBERON:0001969 CML"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "exclamation NCIT:C27966 NCIT:C14168 NCIT:C28078 NCIT:C71732 pregnancy status AJCC UO NCIT:C53553 weight NCIT:C28077 NCIT:C65106 organism part CHEBI:6801 tumor grade Ann Arbor stage NCIT:C14169 sex GDPR HANCESTRO:0006 NCIT:C16358 NCIT:C81328 PR NCIT:C65107 individual TNM NCIT:C4870 ancestry category TNM staging NCIT:C15313 MONDO NCIT:C28079 NCIT:C15632 MONDO:0005044 organism NCIT:C15329 HANCESTRO:0009 PD PREFERRED NOTE age NCIT:C65108 NCI pre-existing condition CHEBI:28748 NCIT:C53556 IV NCIT:C68804 NCIT:C14174 secondary condition NCIT:C18058 NCIT:C15445 CHEBI:41774 IMPORTANT treatment status MONDO:0005300 disease stage ER SDRF MONDO:0005148 body mass index MONDO:0011122 NCIT:C18213 NCIT:C53555 gestational age treatment alcohol consumption breast cancer subtype HANCESTRO disease II sampling time point compound NCIT:C27971 HANCESTRO:0005 BMI time post treatment diet NCIT:C53554 MONDO:0004995 ID NCIT:C81327 medication history III NCIT:C15262 NCIT:C18206 NCIT:C28054 HANCESTRO:0010 smoking status HIPAA MONDO:0002050 MONDO:0004979 ethnicity Dukes stage menopausal status NCIT:C14167 EFO height NCIT dose treatment response ACE NCIT:C27970 CHEBI:27899 NCIT:C28076 prior treatment NCIT:C62723"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C27966 NCIT:C14168 NCIT:C28078 NCIT:C71732 pregnancy status AJCC UO NCIT:C53553 weight NCIT:C28077 NCIT:C65106 organism part CHEBI:6801 tumor grade Ann Arbor stage NCIT:C14169 sex GDPR HANCESTRO:0006 NCIT:C16358 NCIT:C81328 PR NCIT:C65107 individual TNM NCIT:C4870 ancestry category TNM staging NCIT:C15313 MONDO NCIT:C28079 NCIT:C15632 MONDO:0005044 organism NCIT:C15329 HANCESTRO:0009 PD PREFERRED age NCIT:C65108 NCI pre-existing condition CHEBI:28748 NCIT:C53556 IV NCIT:C68804 NCIT:C14174 secondary condition NCIT:C18058 NCIT:C15445 CHEBI:41774 treatment status MONDO:0005300 disease stage ER SDRF MONDO:0005148 body mass index MONDO:0011122 NCIT:C18213 NCIT:C53555 gestational age treatment alcohol consumption breast cancer subtype HANCESTRO disease II sampling time point compound NCIT:C27971 HANCESTRO:0005 BMI time post treatment diet NCIT:C53554 MONDO:0004995 ID NCIT:C81327 medication history III NCIT:C15262 NCIT:C18206 NCIT:C28054 HANCESTRO:0010 smoking status HIPAA MONDO:0002050 MONDO:0004979 ethnicity Dukes stage menopausal status NCIT:C14167 EFO height NCIT dose treatment response ACE NCIT:C27970 CHEBI:27899 NCIT:C28076 prior treatment NCIT:C62723"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "TOF exclamation UNIMOD:1 SDRF RPPA DDA LTQ PSI TA ST MS:1001306 PRIDE SCIEX ID cleavage agent details UNIMOD:21 SHOULD TIP URI RECOMMENDED NOTE URL scan window upper limit precursor mass tolerance UNIMOD MRM ELISA TS AC HF data file label proteomics data acquisition method modification parameters file uri UNIMOD:737 proteomexchange accession number sample MS:1001313 scan window lower limit MM MGF MSD TMT CF UNIMOD:35 KR DIA MOD CS MS1 scan range PP MS:1001309 fraction NT SILAC technical replicate MUST UNIMOD:4 FTP MS:1001251 REQUIRED MS:1001303 MS:1001917 IMPORTANT SRM PRM RAW fraction identifier MS2 analyzer type fragment mass tolerance PRIDE:0000663 MT instrument MS XL"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "TOF UNIMOD:1 SDRF RPPA DDA LTQ PSI TA ST MS:1001306 PRIDE SCIEX ID cleavage agent details UNIMOD:21 SHOULD URI precursor mass tolerance RECOMMENDED scan window upper limit URL UNIMOD MRM ELISA TS AC HF data file label proteomics data acquisition method modification parameters file uri UNIMOD:737 proteomexchange accession number MS:1001313 scan window lower limit MM MGF MSD TMT CF UNIMOD:35 KR DIA MOD CS MS1 scan range PP MS:1001309 NT SILAC technical replicate MUST UNIMOD:4 FTP MS:1001251 REQUIRED MS:1001303 MS:1001917 SRM PRM RAW fraction identifier MS2 analyzer type fragment mass tolerance PRIDE:0000663 MT instrument MS XL"
  }
]